Can transcriptomics guide the management of SLE-associated APS?

Nikolopoulos, D. et al. Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2024-225664 (2024).

Article  PubMed  Google Scholar 

Xourgia, E. & Tektonidou, M. G. Type I interferon gene expression in antiphospholipid syndrome: Pathogenetic, clinical and therapeutic implications. J. Autoimmun. 104, 102311 (2019).

Article  CAS  PubMed  Google Scholar 

Verrou, K. M., Sfikakis, P. P. & Tektonidou, M. G. Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome. J. Autoimmun. 134, 102978 (2023).

Article  CAS  PubMed  Google Scholar 

Tambralli, A., Gockman, K. & Knight, J. S. NETs in APS: current knowledge and future perspectives. Curr. Rheumatol. Rep. 22, 67 (2020).

Article  PubMed  Google Scholar 

Pappa, M. et al. Augmented oxidative stress, accumulation of DNA damage and impaired DNA repair mechanisms in thrombotic primary antiphospholipid syndrome. Clin. Immunol. 254, 109693 (2023).

Article  CAS  PubMed  Google Scholar 

Wozniak, E., Broncel, M., Bukowska, B. & Gorzelak-Pabis, P. The protective effect of dabigatran and rivaroxaban on DNA oxidative changes in a model of vascular endothelial damage with oxidized cholesterol. Int. J. Mol. Sci. 21, 1953 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldhaber, S. Z. et al. Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: findings from RE-COVER(R), RE-COVER II, and RE-MEDY. Vasc. Med. 21, 506–514 (2016).

Article  CAS  PubMed  Google Scholar 

Tektonidou, M. G. et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann. Rheum. Dis. 78, 1296–1304 (2019).

Article  CAS  PubMed  Google Scholar 

Zuily, S. et al. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J. Thromb. Haemost. 18, 2126–2137 (2020).

Article  CAS  PubMed  Google Scholar 

Khairani, C. D. et al. Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J. Am. Coll. Cardiol. 81, 16–30 (2023).

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif